Citadel Advisors’s Vincerx Pharma, Inc. Warrant VINCW Stock Holding History

Citadel Advisors’s Portfolio VINCW Stock Details VINCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-425,109	Closed	-$1.72M	–	14959
2021 Q1	$1.72M	Buy	+425,109	New	+$1.72M	﹤0.01%	6766

Citadel Advisors's VINCW Position: Q2 2021 in Review

Citadel Advisors sold out of Vincerx Pharma, Inc. Warrant (VINCW) in Q2 2021, closing a stake of 425,109 shares — an estimated $1.72M sold.

Citadel Advisors first reported a position in VINCW in Q1 2021 and held it in 1 quarter. The position peaked at $1.72M in Q1 2021. 0 funds tracked by Wall St. Rank hold VINCW as of Q2 2021.

Citadel Advisors reported no remaining Vincerx Pharma, Inc. Warrant position as of Q2 2021 after selling out during the quarter.
Citadel Advisors sold 425,109 Vincerx Pharma, Inc. Warrant shares in Q2 2021, an estimated $1.72M.
Citadel Advisors first reported a position in Vincerx Pharma, Inc. Warrant in Q1 2021 and held it in 1 quarter.
Citadel Advisors's Vincerx Pharma, Inc. Warrant position peaked at $1.72M in Q1 2021.
0 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Warrant as of Q2 2021.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.